• 1
    Trowsdale, J., Genetic and functional relationships between MHC and NK receptor genes. Immunity 2001. 15: 363374.
  • 2
    Valiante, N. M., Uhrberg, M., Shilling, H. G., Lienert-Weidenbach, K., Arnett, K. L., D'Andrea, A., Phillips, J. H., Lanier, L. L. and Parham, P., Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997. 7: 739751.
  • 3
    Chan, H. W., Kurago, Z. B., Stewart, C. A., Wilson, M. J., Martin, M. P., Mace, B. E., Carrington, M., Trowsdale, J. and Lutz, C. T., DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J. Exp. Med. 2003. 197: 245255.
  • 4
    Moretta, A., Tambussi, G., Bottino, C., Tripodi, G., Merli, A., Ciccone, E., Pantaleo, G. and Moretta, L., A novel surface antigen expressed by a subset of human CD3CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. J. Exp. Med. 1990. 171: 695714.
  • 5
    Anfossi, N., Pascal, V., Vivier, E. and Ugolini, S., Biology of T memory type 1 cells. Immunol. Rev. 2001. 181: 269278.
  • 6
    Stewart, C. A., Van Bergen, J. and Trowsdale, J., Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters. J. Immunol. 2003. 170: 60736081.
  • 7
    Santourlidis, S., Trompeter, H. I., Weinhold, S., Eisermann, B., Meyer, K. L., Wernet, P. and Uhrberg, M., Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J. Immunol. 2002. 169: 42534261.
  • 8
    Trowsdale, J., Barten, R., Haude, A., Stewart, C. A., Beck, S. and Wilson, M. J., The genomic context of natural killer receptor extended gene families. Immunol. Rev. 2001. 181: 2038.
  • 9
    Vilches, C., Gardiner, C. M. and Parham, P., Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. J. Immunol. 2000. 165: 64166421.
  • 10
    Van Bergen, J., Thompson, A., van der, S. A., Ottenhoff, T. H., Gussekloo, J. and Koning, F., Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J. Immunol. 2004. 173: 67196726.
  • 11
    Namekawa, T., Snyder, M. R., Yen, J. H., Goehring, B. E., Leibson, P. J., Weyand, C. M. and Goronzy, J. J., Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J. Immunol. 2000. 165: 11381145.
  • 12
    Gazit, R., Garty, B. Z., Monselise, Y., Hoffer, V., Finkelstein, Y., Markel, G., Katz, G., Hanna, J., Achdout, H., Gruda, R. et al., Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood 2004. 103: 19651966.
  • 13
    Doetzlhofer, A., Rotheneder, H., Lagger, G., Koranda, M., Kurtev, V., Brosch, G., Wintersberger, E. and Seiser, C., Histone deacetylase 1 can repress transcription by binding to Sp1. Mol. Cell Biol. 1999. 19: 55045511.
  • 14
    Durst, K. L. and Hiebert, S. W., Role of RUNX family members in transcriptional repression and gene silencing. Oncogene 2004. 23: 42204224.
  • 15
    Thomas, M. J. and Seto, E., Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 1999. 236: 197208.
  • 16
    Yang, W. M., Inouye, C., Zeng, Y., Bearss, D. and Seto, E., Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl. Acad. Sci. USA 1996. 93: 1284512850.
  • 17
    Rezai-Zadeh, N., Zhang, X., Namour, F., Fejer, G., Wen, Y. D., Yao, Y. L., Gyory, I., Wright, K. and Seto, E., Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1. Genes Dev. 2003. 17: 10191029.
  • 18
    Yokota, T., Matsuzaki, Y., Miyazawa, K., Zindy, F., Roussel, M. F. and Sakai, T., Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Oncogene 2004. 23: 53405349.
  • 19
    Fuks, F., Hurd, P. J., Deplus, R. and Kouzarides, T., The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res. 2003. 31: 23052312.
  • 20
    Held, W., Kunz, B., Lowin-Kropf, B., van de, W. M. and Clevers, H., Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1. Immunity 1999. 11: 433442.
  • 21
    Kunz, B. and Held, W., Positive and negative roles of the trans-acting T cell factor-1 for the acquisition of distinct Ly-49 MHC class I receptors by NK cells. J. Immunol. 2001. 166: 61816187.
  • 22
    Saleh, A., Makrigiannis, A. P., Hodge, D. L. and Anderson, S. K., Identification of a novel Ly49 promoter that is active in bone marrow and fetal thymus. J. Immunol. 2002. 168: 51635169.
  • 23
    Saleh, A., Davies, G. E., Pascal, V., Wright, P. W., Hodge, D. L., Cho, E. H., Lockett, S. J., Abshari, M. and Anderson, S. K., Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity 2004. 1: 5566.
  • 24
    Martin, M. P., Gao, X., Lee, J. H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., Trowsdale, J. et al., Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 2002. 31: 429434.
  • 25
    Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al., HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004. 305: 872874.
  • 26
    Hiby, S. E., Walker, J. J., O'shaughnessy, K. M., Redman, C. W., Carrington, M., Trowsdale, J. and Moffett, A., Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 2004. 200: 957965.
  • 27
    van der Slik, A. R., Koeleman, B. P., Verduijn, W., Bruining, G. J., Roep, B. O. and Giphart, M. J., KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 2003. 52: 26392642.
  • 28
    Martin, M. P., Nelson, G., Lee, J. H., Pellett, F., Gao, X., Wade, J., Wilson, M. J., Trowsdale, J., Gladman, D. and Carrington, M., Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J. Immunol. 2002. 169: 28182822.
  • 29
    Yen, J. H., Moore, B. E., Nakajima, T., Scholl, D., Schaid, D. J., Weyand, C. M. and Goronzy, J. J., Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J. Exp. Med. 2001. 193: 11591167.
  • 30
    Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., Martelli, M. F. and Velardi, A., Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002. 295: 20972100.
  • 31
    Ruggeri, L., Capanni, M., Casucci, M., Volpi, I., Tosti, A., Perruccio, K., Urbani, E., Negrin, R. S., Martelli, M. F. and Velardi, A., Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999. 94: 333339.
  • 32
    Giebel, S., Locatelli, F., Lamparelli, T., Velardi, A., Davies, S., Frumento, G., Maccario, R., Bonetti, F., Wojnar, J., Martinetti, M. et al., Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003. 102: 814819.
  • 33
    Davies, S. M., Ruggieri, L., DeFor, T., Wagner, J. E., Weisdorf, D. J., Miller, J. S., Velardi, A. and Blazar, B. R., Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Blood 2002. 100: 38253827.
  • 34
    Beelen, D. W., Ottinger, H., Ferencik, S., Elmaagacli, A. H., Peceny, R., Trenschel, R. and Grosse-Wilde, H., Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. Blood 2004. 105: 25942600.
  • 35
    Zhang, Y. and Lichtenheld, M. G., Non-killer cell-specific transcription factors silence the perforin promoter. J. Immunol. 1997. 158: 17341741.
  • 36
    Wilson, M. J., Torkar, M., Haude, A., Milne, S., Jones, T., Sheer, D., Beck, S. and Trowsdale, J., Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl. Acad. Sci. USA 2000. 97: 47784783.